Dr. Carolina Haass-Koffler is a translational Investigator who coalesces preclinical and clinical research towards examining biobehavioral mechanisms of addiction and developing novel medications. Her education includes chemistry from the University of California, Berkeley, pharmacology and neuroscience from the University of California, San Francisco and Addiction Medicine from Brown University. During her academic career, she has developed an interdisciplinary skill-set that is helping her to conceptualize and execute bench-to-bedside research and to facilitate the cross-talk between academia, NIH and the pharmaceutical industry.
Haass-Koffler's Laboratory: Clinical Neuroscience
| Monnig MA, Clark SE, Avila JC, Sokolovsky AW, Treloar Padovano H, Goodyear K, Aston ER, Haass-Koffler CL, Tidey JW, Ahluwalia JS, Monti PM. "COVID-19-Related Stressors and Clinical Mental Health Symptoms in a Northeast US Sample." International Journal of Environmental Research and Public Health, vol. 20, no. 2, 2023, pp. 1367. |
| Soliman P, Amaefuna I, Gully B, Haass-Koffler CL. "Evaluating the Readability of Online Patient Facing Resources for Alcohol Use Disorder." Alcohol, 2023. |
| Haass-Koffler CL, Magill M, Cannella N, Brown JC, Aoun EG, Cioe PA, Sinha R, Swift RM, Ciccocioppo R, Leggio L. "Mifepristone as a pharmacological intervention for stress-induced alcohol craving: A human laboratory study." Addiction biology, vol. 28, no. 7, 2023, pp. e13288. |
| Gully BJ, Eaton E, Capone C, Haass-Koffler CL. "Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy." Journal of Psychopharmacology, 2023, pp. 2698811231200880. |
| Haass-Koffler CL. "Utilizing precision medicine to treat alcohol use disorder: A commentary on the α1 receptor antagonist." Alcohol (Hoboken, N.J.), vol. 47, no. 3, 2023, pp. 432-434. |
| Haass-Koffler CL, Francis TC, Gandhi P, Patel R, Naemuddin M, Nielsen CK, Bartlett SE, Bonci A, Vasile S, Hood BL, Suyama E, Hedrick MP, Smith LH, Limpert AS, Roberto M, Cosford NDP, Sheffler DJ. "Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding protein." SLAS discovery : advancing life sciences R & D, vol. 27, no. 8, 2022, pp. 448-459. |
| Varodayan FP, Patel RR, Matzeu A, Wolfe SA, Curley DE, Khom S, Gandhi PJ, Rodriguez L, Bajo M, D'Ambrosio S, Sun H, Kerr TM, Gonzales RA, Leggio L, Natividad LA, Haass-Koffler CL, Martin-Fardon R, Roberto M. "The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder." Biological Psychiatry, vol. 91, no. 12, 2022, pp. 1008-1018. |
| Lunerti V, Li H, Benvenuti F, Shen Q, Domi A, Soverchia L, Concetta Di Martino RM, Bottegoni G, Haass-Koffler CL, Cannella N. "The multitarget FAAH inhibitor/D3 partial agonist ARN15381 decreases nicotine self-administration in male rats." European journal of pharmacology, vol. 928, 2022, pp. 175088. |
| Curley DE, Vasaturo-Kolodner TR, Cannella N, Ciccocioppo R, Haass-Koffler CL. "Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies." Neuropsychopharmacology, 2022. |
| Goodyear K, Vasaturo-Kolodner TR, Kenna GA, Swift RM, Leggio L, Haass-Koffler CL. "Alcohol-related changes in behaviors and characteristics from the baseline to the randomization session for treatment and non-treatment seeking participants with alcohol use disorder." The American Journal of Drug and Alcohol Abuse, 2021, pp. 1-9. |
| Haass-Koffler CL, Perciballi R, Magill M, Loche A, Cacciaglia R, Leggio L, Swift RM. "An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder." Psychopharmacology, 2021. |
| Stopponi S, Fotio Y, Cifani C, Li H, Haass-Koffler CL, Cannella N, Demopulos G, Gaitanaris G, Ciccocioppo R. "Andrographis paniculata and Its Main Bioactive Ingredient Andrographolide Decrease Alcohol Drinking and Seeking in Rats Through Activation of Nuclear PPARγ Pathway." Alcohol and Alcoholism, 2021. |
| Monnig, Mollie A, Treloar Padovano, Hayley, Sokolovsky, Alexander W, DeCost, Grace, Aston, Elizabeth R, Haass-Koffler, Carolina L, Szapary, Claire, Moyo, Patience, Avila, Jaqueline C, Tidey, Jennifer W, Monti, Peter M, Ahluwalia, Jasjit S. "Associations of Substance Use With Behavioral Adherence to Centers for Disease Control and Prevention Guidelines for COVID-19 Mitigation: Survey Study." JMIR Public Health and Surveillance, vol. 7, no. 11, 2021, pp. e29319. |
| Curley DE, Webb AE, Sheffler DJ, Haass-Koffler CL. "Corticotropin Releasing Factor Binding Protein as a Novel Target to Restore Brain Homeostasis: Lessons Learned From Alcohol Use Disorder Research." Frontiers in Behavioral Neuroscience, vol. 15, 2021, pp. 786855. |
| Farokhnia M, Abshire KM, Hammer A, Deschaine SL, Saravanakumar A, Cobbina E, You ZB, Haass-Koffler CL, Lee MR, Akhlaghi F, Leggio L. "Neuroendocrine Response to Exogenous Ghrelin Administration, Combined With Alcohol, in Heavy-Drinking Individuals: Findings From a Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study." The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), vol. 24, no. 6, 2021, pp. 464-476. |
| Brown ZE, Portis SM, Fleig CL, Vasaturo-Kolodner T, Swift RM, Haass-Koffler CL. "Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic." Alcohol, vol. 92, 2021, pp. 21-24. |
| Zywiak, William H., Haass-Koffler, Carolina L., Olinsky, Alan, Cavicchio, Leonardo, Ciliberto, David J. "Some Alcohol-Related Consequences for Women May Signal an Escape from Interpersonal Violence." Advances in Applied Sociology, vol. 11, no. 04, 2021, pp. 177-184. |
| Haass-Koffler CL, Souza RD, Wilmott JP, Aston ER, Song JH. "A Combined Alcohol and Smoking Cue-Reactivity Paradigm in People Who Drink Heavily and Smoke Cigarettes: Preliminary Findings." Alcohol and Alcoholism, 2020. |
| Haass-Koffler CL, Perciballi R. "Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use Disorder." Alcohol and Alcoholism, 2020. |
| Haass-Koffler CL, Perciballi R, Brown ZE, Lee MR, Zywiak WH, Kurtis J, Swift RM, Leggio L. "Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β-Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders." The American Journal on Addictions, 2020. |
| Haass-Koffler CL, Piacentino D, Li X, Long VM, Lee MR, Swift RM, Kenna GA, Leggio L. "Differences in Sociodemographic and Alcohol-Related Clinical Characteristics Between Treatment Seekers and Nontreatment Seekers and Their Role in Predicting Outcomes in the COMBINE Study of Alcohol Use Disorder." Alcoholism: Clinical and Experimental Research, 2020. |
| Samantha M. Portis, Carolina L. Haass-Koffler. "New Microglial Mechanisms Revealed in Alcohol Use Disorder: How Does That Translate?." Biological Psy, vol. 88, no. 12, 2020, pp. 893-895. |
| Haass-Koffler CL. "Protein Tyrosine Phosphatase β/ζ and Alcohol Use Disorder: A Commentary." Alcoholism: Clinical and Experimental Research, 2020. |
| Haass-Koffler CL, Cannella N, Ciccocioppo R. "Translational dynamics of alcohol tolerance of preclinical models and human laboratory studies." Experimental and Clinical Psychopharmacology, 2020. |
| Haass-Koffler CL, Schank JR. "Translational Research in the Neurobiological Mechanisms of Alcohol and Substance Use Disorders." Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2020. |
| Haass-Koffler CL, Long VM, Farokhnia M, Magill M, Kenna GA, Swift RM, Leggio L. "Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study." Neuropharmacology, vol. 158, 2019, pp. 107711. |
| Goodyear K, Haass-Koffler CL. "Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations." Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2019. |
|
Tunstall BJ, Lorrai I, McConnell SA, Gazo KL, Zallar LJ, Di Guglielmo G, Haass-Koffler CL, Repunte-Canonigo V, Koob GF, Vendruscolo LF, Sanna PP.
"Probenecid Reduces Alcohol Drinking in Rats: is Pannexin1 a Novel Therapeutic Target for Alcohol Use Disorder?." Alcohol and Alcoholism, 2019.
|
| Tunstall BJ, Lorrai I, McConnell SA, Gazo KL, Zallar LJ, de Guglielmo G, Hoang I, Haass-Koffler CL, Repunte-Canonigo V, Koob GF, Vendruscolo LF, Sanna PP. "Probenecid Reduces Alcohol Drinking in Rodents. Is Pannexin1 a Novel Therapeutic Target for Alcohol Use Disorder?." Alcohol and Alcoholism, vol. 54, no. 5, 2019, pp. 497-502. |
|
Haass-Koffler CL and McCance-Katz EF.
"The Pharmacology of Nonalcoholic Sedative Hypnotics." Essentials of Addiction Medicine, edited by Shannon Miller, Richard Rosenthal, David Fiellin, and Richard Saitz, American Society Addiction Medicine, 2019.
|
|
Haass-Koffler CL and McCance-Katz EF.
"The Pharmacology of nonalcoholic Sedative Hypnotics." Principles of Addiction Medicine, edited by Shannon Miller, Richard Rosenthal, David Fiellin, and Richard Saitz, American Society Addicition Medicine, 2019.
|
| Haass-Koffler, Carolina L, Goodyear, Kimberly, Loche, Antonella, Long, Victoria M, Lobina, Carla, Tran, Harrison H, Cacciaglia, Roberto, Swift, Robert M, Colombo, Giancarlo, Leggio, Lorenzo. "Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: A translational study in rats and humans." Journal of Psychopharmacology, vol. 32, no. 2, 2018, pp. 163-173. |
| Haass-Koffler, Carolina L, Goodyear, Kimberly, Zywiak, William H, Leggio, Lorenzo, Kenna, George A, Swift, Robert M. "Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study." Alcohol and Alcoholism, vol. 53, no. 3, 2018, pp. 268-276. |
| Haass-Koffler, Carolina L, Goodyear, Kimberly, Zywiak, William H, Leggio, Lorenzo, Kenna, George A, Swift, Robert M. "Corrigendum: Comparing and Combining Topiramate and Aripiprazole on Alcohol-Related Outcomes in a Human Laboratory Study." Alcohol and Alcoholism, vol. 53, no. 4, 2018, pp. 500. |
| Haass-Koffler CL, Swift RM, Leggio L. "Noradrenergic targets for the treatment of alcohol use disorder." Psychopharmacology, vol. 235, no. 6, 2018, pp. 1625-1634. |
| Goodyear K, Haass-Koffler CL, Chavanne D. "Opioid use and stigma: The role of gender, language and precipitating events." Drug and Alcohol Dependence, vol. 185, 2018, pp. 339-346. |
| Haass-Koffler, Carolina L., Goodyear, Kimberly, Long, Victoria M., Tran, Harrison H., Loche, Antonella, Cacciaglia, Roberto, Swift, Robert M., Leggio, Lorenzo. "A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers." European Journal of Pharmaceutical Sciences, vol. 109, 2017, pp. 78-85. |
| Aoun EG, Jimenez VA, Vendruscolo LF, Walter NAR, Barbier E, Ferrulli A, Haass-Koffler CL, Darakjian P, Lee MR, Addolorato G, Heilig M, Hitzemann R, Koob GF, Grant KA, Leggio L. "A relationship between the aldosterone-mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans." Molecular Psychiatry, 2017. |
| Haass-Koffler CL, Akhlaghi F, Swift RM, Leggio L. "Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks?." Journal of Psychopharmacology, vol. 31, no. 7, 2017, pp. 812-818. |
| Haass-Koffler CL, Goodyear K, Long VM, Tran HH, Loche A, Cacciaglia R, Swift RM, Leggio L. "Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parameters." Data in Brief, vol. 15, 2017, pp. 407-413. |
| Haass-Koffler CL, Goodyear K, Zywiak WH, Magill M, Eltinge SE, Wallace PM, Long VM, Jayaram-Lindström N, Swift RM, Kenna GA, Leggio L. "Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin." Drug and Alcohol Dependence, vol. 177, 2017, pp. 23-28. |
| Haass-Koffler CL. "The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system?." Alcohol, vol. 72, 2017, pp. 3-8. |
| Haass-Koffler CL, Henry AT, Melkus G, Simms JA, Naemmuddin M, Nielsen CK, Lasek AW, Magill M, Schwandt ML, Momenan R, Hodgkinson CA, Bartlett SE, Swift RM, Bonci A, Leggio L. "Defining the role of corticotropin releasing factor binding protein in alcohol consumption." Translational psychiatry, vol. 6, no. 11, 2016, pp. e953. |
| Haass-Koffler CL, Giovenco DE, Lee MR, Zywiak WH, de la Monte SM, Kenna GA, Swift RM, Leggio L. "Serum Insulin Levels Are Reduced by Intravenous Ghrelin Administration but Do Not Correlate with Alcohol Craving in Alcohol-Dependent Individuals." The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 2016. |
| Haass-Koffler CL, Leggio L, Davidson D, Swift RM. "Effects of Idazoxan on Alcohol Pharmacokinetics and Intoxication: A Preliminary Human Laboratory Study." Alcoholism: Clinical and Experimental Research, vol. 39, no. 4, 2015, pp. 594-602. |
| Haass-Koffler CL, Aoun EG, Swift RM, de la Monte SM, Kenna GA, Leggio L. "Leptin levels are reduced by intravenous ghrelin administration and correlated with cue-induced alcohol craving." Translational psychiatry, vol. 5, no. 9, 2015, pp. e646. |
| Aoun, E. G., Lee, M. R., Haass-Koffler, C. L., Swift, R. M., Addolorato, G., Kenna, G. A., Leggio, L. "Relationship Between the Thyroid Axis and Alcohol Craving." Alcohol and Alcoholism, vol. 50, no. 1, 2015, pp. 24-9. |
| Kenna GA, Haass-Koffler CL, Zywiak WH, Edwards SM, Brickley MB, Swift RM, Leggio L. "Role of the α<sub>1</sub> blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial." Addiction biology, 2015. |
| Kenna, George A., Zywiak, William H., Swift, Robert M., McGeary, John E., Clifford, James S., Shoaff, Jessica R., Fricchione, Samuel, Brickley, Michael, Beaucage, Kayla, Haass-Koffler, Carolina L., Leggio, Lorenzo. "Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: Exploratory findings." Alcohol, vol. 48, no. 6, 2014, pp. 515-22. |
| Kenna, George A., Zywiak, William H., Swift, Robert M., McGeary, John E., Clifford, James S., Shoaff, Jessica R., Vuittonet, Cynthia, Fricchione, Samuel, Brickley, Michael, Beaucage, Kayla, Haass-Koffler, Carolina L., Leggio, Lorenzo. "Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study." Alcoholism: Clinical and Experimental Research, vol. 38, no. 6, 2014, pp. 1567-74. |
| Haass-Koffler CL, Leggio L, Kenna GA. "Pharmacological approaches to reducing craving in patients with alcohol use disorders." CNS drugs, vol. 28, no. 4, 2014, pp. 343-60. |
| Vuittonet CL, Halse M, Leggio L, Fricchione SB, Brickley M, Haass-Koffler CL, Tavares T, Swift RM, Kenna GA. "Pharmacotherapy for alcoholic patients with alcoholic liver disease." American Journal of Health-system Pharmacy, vol. 71, no. 15, 2014, pp. 1265-76. |
| Haass-Koffler CL, Kenna GA. "Bacchus by Caravaggio as the Visual Diagnosis of Alcohol Use Disorder from the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)." Frontiers in Psychiatry, vol. 4, 2013, pp. 86. |
| Chatterjee S, Santos N, Holgate J, Haass-Koffler CL, Hopf FW, Kharazia V, Lester H, Bonci A, Bartlett SE. "The α5 subunit regulates the expression and function of α4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental area." PLoS ONE, vol. 8, no. 7, 2013, pp. e68300. |
| Haass-Koffler CL, Naeemuddin M, Bartlett SE. "An analytical tool that quantifies cellular morphology changes from three-dimensional fluorescence images." Journal of visualized experiments : JoVE, no. 66, 2012, pp. e4233. |
| Simms JA, Haass-Koffler CL, Bito-Onon J, Li R, Bartlett SE. "Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking." Neuropsychopharmacology, vol. 37, no. 4, 2012, pp. 906-18. |
| Haass-Koffler CL, Bartlett SE. "Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity." Frontiers in molecular neuroscience, vol. 5, 2012, pp. 91. |
| Haass-Koffler CL and McCance-Katz EF. "Substance Abuse: A Comprehensive Textbook Management of Associated Medical Conditions: Medication Interactions.", edited by Lowinson & Ruiz's, Lippincott, Williams, and Wilkins, 2011. |
NIH/NIDA UE5 DA056914 (PI: Breazeal/MIT: Subaward Haass-Koffler/Brown) Program on Entrepreneurship and Innovation for Biomedical Product Development Date received: 7/15/22
NIH/NIAAA R01 AA027760 (PI: Haass-Koffler) A focus on alpha-1 blockade as a novel pharmacological treatment for alcohol use disorder. Diversity Supplement. Date received: 9/9/21
NIH/NIAAA R21 AA027614 (PI: Haass-Koffler) Probenecid as a pharmacotherapy for alcohol use disorder. Data received: 04/10/2020
NIH/NIAAA R01 AA027760 (PI: Haass-Koffler) A focus on alpha-1 blockade as a novel pharmacological treatment for alcohol use disorder. Date received: 9/9/19
NIH/NIGMS P20 GM130414 (PI: Monti; PL: Haass-Koffler) Oxytocin to Reduce Stress-Induced Craving in Patients with Opioid Use Disorder. Date recived 8/1/19
NIH/NIAAA R01 AA026589 (PI: Sheffler/SBP; Subaward PI: Haass-Koffler/Brown) Lead optimization of novel CRFBP-CRFR2 complex modulators for alcohol use disorder. Date received: 5/1/19
NIH/NIAAA K01AA023867 (PI Haass-Koffler) Mifepristone As A Pharmacological Intervention For Stress-Induced Alcohol Drinking. Date received: 4/1/16
Halon Foundation (MPI: Haass-Koffler, Kahun, McGeary, White) The Stress Factor: Understanding the Role of Norepinephrine in Alcohol Use Disorder. Date recieved: 7/31/19
Rohsenow Reserch Excellence Award Brown University (PI: Haass-Koffler) Integrated cue-reactivity paradigm to assess selective attention to simultaneous alcohol and smoking cues: A pilot study, Date received: 9/8/17
CAAS Research Excellence Award Brown University (PI: Haass-Koffler) Pilot Study on the safety and efficacy of Mifepristone for the prevention of relapses of alcohol drinking. Date received: 1/15/14
Strategic Opportunities Exploratory Award University of California, San Francisco (UCSF) (PI: Haass-Koffler) Preclinical imaging study of Corticotropin Releasing Factor Binding Protein using 7T Magnetic Resonance Imaging (MRI). Date received: 1/15/12
NIH/NIAAA R21AA019994 (PIs: Leggio and Kenna) - Doxazosin an apha-1 Antagonist for Alcohol Dependence. ROLE: Fellow, Date received: 9/1/11
NIH/NIDA R21DA029966 (PI: Bartlett) - Identifying Chemical Modulators of CRF-Binding Protein and CRF-Receptor Complexes. ROLE: Fellow, Date received: 4/1/11
BOOKS AND BOOK CHAPTERS
Haass-Koffler CL and McCance-Katz EF. Lowinson & Ruiz's (Eds), Substance Abuse: A Comprehensive Textbook, Fifth Edition, Section 7: Management of Associated Medical Conditions, 53: Medication Interactions. Lippincott Wilkins, 2011; JAMA 307(17):1868-1869. doi:10.1001/jama.307.17.1868 2012
Haass-Koffler CL and McCance-Katz EF. Principles of Addiction Medicine, 6th Edition, Chapter 8: The Pharmacology of nonalcoholic Sedative Hypnotics, American Society Addiction Medicine (ASAM) edited by Miller S, Rosenthal R, Fiellin D, and Saitz R, 2018
Haass-Koffler CL and McCance-Katz EF. Essentials of Addiction Medicine, 6th Edition, Chapter 8: The Pharmacology of Nonalcoholic Sedative Hypnotics, American Society Addiction Medicine (ASAM) edited by Miller S, Rosenthal R, Fiellin D, and Saitz R, 2019
Haass-Koffler CL and McCance-Katz EF. Principles of Addiction Medicine, 7th Edition, Section 2: Pharmacology, Chapter 10: The Pharmacology of Nonalcoholic Sedative Hypnotics, American Society Addiction Medicine (ASAM) edited by Miller S, Rosenthal R, Saitz R, Tetrult J, Levy S and Saxon A, (submitted, expected 2023)
| Year | Degree | Institution |
|---|---|---|
| 2022 | PhD | Università degli Studi di Camerino |
| 2009 | PharmD | University of California, San Francisco |
| 2002 | BS | University of California-Berkeley |
| Postdoctoral Fellow | Brown University, Center for Alcohol and Addiction Studies | 2013-2016 | Providence, RI, United States |
| Clinical Fellow | School of Medicine, University of California, San Francisco, Pharmacology and Experimental Therapeutics | 2009-2012 | San Francisco, CA, United States |
| Postdoctoral Fellow | University California, San Francisco, Ernest Gallo Clinic and Research Center | 2009-2012 | San Francisco, CA, United States |
2020
2019
2018
2017
2016
2015
2014
2013
2012
2009
2008
| Name | Title |
|---|---|
| Kahler, Christopher | Professor of Behavioral and Social Sciences, Director of Alcohol and Addiction Studies, Professor of Psychiatry and Human Behavior |
| Kaun, Karla | Associate Professor of Neuroscience |
| Magill, Molly | Professor of Behavioral and Social Sciences (Research) |
| McGeary, John | Professor of Psychiatry and Human Behavior |
| Song, Joo-Hyun | Associate Professor of Cognitive and Psychological Sciences |
| Swift, Robert | Professor of Psychiatry and Human Behavior, Professor of Behavioral and Social Sciences |
| White, Tara | Assistant Professor of Behavioral and Social Sciences (Research) |
Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University
Department Behavioral and Social Sciences, School Public Health, Brown University
Carney Institute for Brain Science
Center for Alcohol and Addiction Studies, Brown University
2017 – pres. T32 Core Seminar Series, CAAS, Ethology of Substance Abuse: The role of stress on substance use, craving and relapse, Brown University
2016 - pres. T32 Core Seminar Series, CAAS, Psychosocial and Pharmacologic Treatment of Substance Use Disorders: Pharmacological Treatment for Additions, Brown University
2015 – pres. T32 Core Seminar Series, CAAS, Ethics: Intellectual Properties. Butler Hospital, Brown University
2014 - pres. Exploring Pharmacogentics. Bouvé College of Health Science, Pharmacy School, Northeastern University, Boston, MA
2011 - 2012 Drug-Drug Interaction: Pharmacokinetic and Biopharmaceutical. School of Pharmacy, University of California, San Francisco
2009 - 2012 Imaris Neuroscience, Microscopy and Visualization. Gallo Center, Neuroscience Department, University of California, San Francisco
